Compare funds
Pick up to 10 funds. Compare funds from the same category for a fair reading.
Growth of ₹10,000
Basics
| Nippon India Japan Equity Fund | HDFC Pharma and Healthcare Fund | |
|---|---|---|
| Category | Sectoral / Thematic | Sectoral / Thematic |
| Plan | Direct | Direct |
| Fund house | Nippon India | HDFC |
| NAV | ₹28.1719 | ₹23.6750 |
| NAV date | 20 Nov 2026 | 20 Nov 2026 |
| History | 12.2 years | 3.1 years |
| Expense ratio | 1.5% | 1.1% |
| Stars | ★★★★★ | ★★★★★ |
| Growth Score | 67.10 | 94.50 |
Returns
| Nippon India Japan Equity Fund | HDFC Pharma and Healthcare Fund | |
|---|---|---|
| 1 month | −10.56% | +12.97% |
| 3 months | −10.60% | +7.13% |
| 6 months | −7.14% | +17.84% |
| YTD | +11.43% | +33.73% |
| 1 year | +16.40% | +32.20% |
| 3 years (CAGR) | +16.58% | +30.70% |
| 5 years (CAGR) | +8.37% | — |
| 10 years (CAGR) | +10.12% | — |
| Since launch | +8.89% | +31.83% |
Risk
| Nippon India Japan Equity Fund | HDFC Pharma and Healthcare Fund | |
|---|---|---|
| Volatility | 14.5% | 15.8% |
| Downside volatility | 9.5% | 8.5% |
| Sharpe | 0.69 | 1.53 |
| Sortino | 1.06 | 2.86 |
| Calmar | 1.05 | 2.06 |
| Return / risk | 1.14 | 1.95 |
| Deepest fall | −29.91% | −14.91% |
| Days to recover | 500 | 126 |
| Below its high | −13.87% | +0.00% |
Against benchmark
| Nippon India Japan Equity Fund | HDFC Pharma and Healthcare Fund | |
|---|---|---|
| Alpha | +8.74% | +7.54% |
| Beta | 0.15 | 0.97 |
| R² | 2.6% | 85.0% |
| Up capture | 51.5% | 108.9% |
| Down capture | −8.1% | 71.0% |
| Tracking error | 19.9% | 6.1% |
| Information ratio | 0.21 | 1.17 |
| Treynor | 0.64 | 0.24 |
Consistency
| Nippon India Japan Equity Fund | HDFC Pharma and Healthcare Fund | |
|---|---|---|
| Best 1-year | +58.70% | +67.01% |
| Middle 1-year | +12.04% | +23.25% |
| Worst 1-year | −26.91% | +1.71% |
| 1-year periods with a loss | 21.1% | 0.0% |
| Middle 3-year | +8.38% | +30.22% |
| Positive months | 66.7% | 72.2% |
| Best day | +7.06% | +3.18% |
| Worst day | −7.02% | −3.61% |
| Worst 5% day | −1.68% | −1.51% |
| Positive days | 52.0% | 58.3% |
| NAVs a year | 229 | 247 |
SIP of ₹10,000 a month
| Nippon India Japan Equity Fund | HDFC Pharma and Healthcare Fund | |
|---|---|---|
| 5-year XIRR | +13.98% | — |
| 5-year value | ₹8,57,545 | — |
| 3-year XIRR | +14.02% | +27.71% |
| 1-year XIRR | −2.24% | +41.37% |
Holdings overlap i
Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.